$50 Million Private Placement Announces By Clinical-stage Biotech Company

Unicycive Therapeutics Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company, announced on March 14, 2024, that it has secured a $50 million private placement from undisclosed investors. This news could have significant implications for the company's ongoing research and development efforts, and it may affect future investment opportunities in the biotech sector. $Unicycive Therapeutics(UNCY.US)$